Regarding handling of outliers as per EMEA [Regulatives / Guidelines]

posted by keyurkakkad – 2011-01-27 10:54 (5630 d 22:48 ago) – Posting: # 6497
Views: 2,977

Dear All,

Please can anyone explain as per revised guideline of EMEA (European guidelines) how to handle outliers during pharmacokinetic and statistical analysis?

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
368 visitors (0 registered, 368 guests [including 24 identified bots]).
Forum time: 10:43 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5